Massive healthcare fraud takedown

Federal prosecutors said on April 7 that they had brought three civil and criminal cases tied to more than $500 million in attempted fraud against taxpayer-funded health programs, all announced in a single Justice Department sweep. One case involved Affordable Care Act insurance enrollment, and another centered on COVID-19 testing bills that prosecutors say were fake. (justice.gov) The COVID-19 case started with a simple pitch: “free” test kits online. Prosecutors say New York-based Fast Lab Technologies collected insurance information from people ordering those kits, then billed Medicare, Medicaid, TRICARE, and private insurers for tests that were never properly done. (justice.gov) According to the July 31, 2025 indictment, Fast Lab’s claims said medical professionals watched antigen tests, collected saliva, and ran polymerase chain reaction lab tests. Prosecutors say the reality was that most antigen tests, if taken at all, were done at home, saliva was never sent back, and polymerase chain reaction testing never happened. (justice.gov) Federal prosecutors charged Fast Lab chief executive Cemhan “Jimmy” Biricik and medical director Dr. Martin Perlin, saying the company billed more than $500 million and got paid more than $50 million. Prosecutors also said claims were often submitted before test kits even arrived and that Perlin ordered tests for people he did not treat. (justice.gov) A different branch of the April 7 sweep hit the insurance side of healthcare instead of the lab side. The Justice Department said AP of South Florida used top executives and employees to enroll thousands of vulnerable consumers into fully subsidized Affordable Care Act plans and triggered $141.5 million in unwarranted federal subsidies. (justice.gov) In that same matter, AssuredPartners, the former parent company, agreed to pay $107 million to settle False Claims Act allegations, while AP of South Florida agreed to plead guilty to major fraud against the United States and pay $27.6 million in restitution. The company was not accused of inventing a fake hospital wing or a fake drug, but of turning subsidy paperwork itself into the product. (justice.gov) That is why healthcare fraud so often looks boring right up until the dollar figure lands. The Federal Bureau of Investigation says common schemes include phantom billing, double billing, bogus marketing built around “free” services, and using insurance identification numbers the way a thief uses a stolen credit card. (fbi.gov) The government has been scaling these cases into national operations. In the 2025 National Health Care Fraud Takedown, the Justice Department charged 324 defendants in 50 federal districts over alleged schemes involving $14.6 billion in intended losses, while the Centers for Medicare and Medicaid Services said it had already blocked more than $4 billion in payments and suspended or revoked 205 providers’ billing privileges. (justice.gov) The April 2026 cases show the same weak points from two angles. One weak point is claims systems that will pay for a lab test based on billing codes and doctor orders before anyone proves the sample existed, and the other is enrollment systems that will release subsidies based on application data before anyone confirms the consumer actually asked for the plan. (justice.gov 1) (justice.gov 2) That is why the details in these indictments matter more than the word “takedown.” They read less like movie-style fraud and more like back-office fraud at industrial scale: one website, one ordering doctor, one billing pipeline, and millions of taxpayer dollars moving before the system caught up. (justice.gov)